Literature DB >> 21176972

Additive effects of orexin B and vasoactive intestinal polypeptide on LL-37-mediated antimicrobial activities.

Kouji Ohta1, Mikihiko Kajiya, Tongbo Zhu, Hiromi Nishi, Hani Mawardi, Jane Shin, Leena Elbadawi, Nobuyuki Kamata, Hitoshi Komatsuzawa, Toshihisa Kawai.   

Abstract

The present study examined the bactericidal effects of orexin B (ORXB) and vasoactive intestinal peptide (VIP) alone or combined with cationic antimicrobial peptides, such as LL-37, on Escherichia coli, Pseudomonas aeruginosa, Streptococcus mutans and Staphylococcus aureus. The bactericidal effect of ORXB or VIP alone was detected in low NaCl concentration, but attenuated in physiological NaCl concentration (150 mM). However, such attenuated bactericidal activities of ORXB and VIP in 150 mM NaCl were regained by adding LL-37. Therefore, our results indicate that VIP and ORXB appear to mediate bactericidal effects in concert with LL-37 in the physiological context of mucosal tissue.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21176972      PMCID: PMC3115685          DOI: 10.1016/j.jneuroim.2010.11.009

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  30 in total

Review 1.  Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?

Authors:  Kim A Brogden
Journal:  Nat Rev Microbiol       Date:  2005-03       Impact factor: 60.633

2.  Antimicrobial activity of Substance P and Neuropeptide Y against laboratory strains of bacteria and oral microorganisms.

Authors:  Christopher J Hansen; Kindra K Burnell; Kim A Brogden
Journal:  J Neuroimmunol       Date:  2006-06-30       Impact factor: 3.478

3.  Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli.

Authors:  Xuejun Chen; François Niyonsaba; Hiroko Ushio; Daiju Okuda; Isao Nagaoka; Shigaku Ikeda; Ko Okumura; Hideoki Ogawa
Journal:  J Dermatol Sci       Date:  2005-06-15       Impact factor: 4.563

4.  Induction of outward current by orexin-B in mouse peritoneal macrophages.

Authors:  M Ichinose; M Asai; M Sawada; K Sasaki; Y Oomura
Journal:  FEBS Lett       Date:  1998-11-27       Impact factor: 4.124

Review 5.  VIP and PACAP: very important in pain?

Authors:  T Dickinson; S M Fleetwood-Walker
Journal:  Trends Pharmacol Sci       Date:  1999-08       Impact factor: 14.819

6.  Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides.

Authors:  A Peschel; M Otto; R W Jack; H Kalbacher; G Jung; F Götz
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

7.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.

Authors:  T Sakurai; A Amemiya; M Ishii; I Matsuzaki; R M Chemelli; H Tanaka; S C Williams; J A Richardson; G P Kozlowski; S Wilson; J R Arch; R E Buckingham; A C Haynes; S A Carr; R S Annan; D E McNulty; W S Liu; J A Terrett; N A Elshourbagy; D J Bergsma; M Yanagisawa
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

8.  Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.

Authors:  E V Valore; C H Park; A J Quayle; K R Wiles; P B McCray; T Ganz
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

9.  Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity.

Authors:  Z Oren; J C Lerman; G H Gudmundsson; B Agerberth; Y Shai
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

10.  Inhibitory effect of exogenous orexin a on gastric emptying, plasma leptin, and the distribution of orexin and orexin receptors in the gut and pancreas in man.

Authors:  M Ehrström; T Gustafsson; A Finn; A Kirchgessner; P Grybäck; H Jacobsson; P M Hellström; E Näslund
Journal:  J Clin Endocrinol Metab       Date:  2005-01-25       Impact factor: 5.958

View more
  10 in total

Review 1.  Antidromic neurogenic activity and cutaneous bacterial flora.

Authors:  Marc G J Feuilloley
Journal:  Semin Immunopathol       Date:  2018-03-16       Impact factor: 9.623

2.  The antimicrobial activity of the appetite peptide hormone ghrelin.

Authors:  Christine Min; Kouji Ohta; Mikihito Kajiya; Tongbo Zhu; Kanika Sharma; Jane Shin; Hani Mawardi; Mohammed Howait; Josefine Hirschfeld; Laila Bahammam; Isao Ichimonji; Srinivas Ganta; Mansoor Amiji; Toshihisa Kawai
Journal:  Peptides       Date:  2012-05-22       Impact factor: 3.750

3.  The cecropin-prophenoloxidase regulatory mechanism is a cross-species physiological function in mosquitoes.

Authors:  Wei-Ting Liu; Cheng-Chen Chen; Dar-Der Ji; Wu-Chun Tu
Journal:  iScience       Date:  2022-05-30

4.  Therapeutic efficacy of stable analogues of vasoactive intestinal peptide against pathogens.

Authors:  Jenny Campos-Salinas; Antonio Cavazzuti; Francisco O'Valle; Irene Forte-Lago; Marta Caro; Stephen M Beverley; Mario Delgado; Elena Gonzalez-Rey
Journal:  J Biol Chem       Date:  2014-04-04       Impact factor: 5.157

5.  Human cathelicidin LL-37 and its derivative IG-19 regulate interleukin-32-induced inflammation.

Authors:  Ka-Yee G Choi; Scott Napper; Neeloffer Mookherjee
Journal:  Immunology       Date:  2014-09       Impact factor: 7.397

6.  Protective role of the neuropeptide urocortin II against experimental sepsis and leishmaniasis by direct killing of pathogens.

Authors:  Jenny Campos-Salinas; Marta Caro; Antonio Cavazzuti; Irene Forte-Lago; Stephen M Beverley; Francisco O'Valle; Elena Gonzalez-Rey
Journal:  J Immunol       Date:  2013-11-18       Impact factor: 5.422

7.  Design, Recombinant Fusion Expression and Biological Evaluation of Vasoactive Intestinal Peptide Analogue as Novel Antimicrobial Agent.

Authors:  Chunlan Xu; Yu Guo; Xiangjin Qiao; Xiaoya Shang; Weining Niu; Mingliang Jin
Journal:  Molecules       Date:  2017-11-14       Impact factor: 4.411

Review 8.  Microbiota and gut neuropeptides: a dual action of antimicrobial activity and neuroimmune response.

Authors:  Julia Aresti Sanz; Sahar El Aidy
Journal:  Psychopharmacology (Berl)       Date:  2019-04-17       Impact factor: 4.530

Review 9.  Direct and indirect antimicrobial activities of neuropeptides and their therapeutic potential.

Authors:  Daria Augustyniak; Judyta Nowak; Fionnuala T Lundy
Journal:  Curr Protein Pept Sci       Date:  2012-12       Impact factor: 3.272

Review 10.  Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug-resistant Gram-negatives.

Authors:  María Escobar-Salom; Gabriel Torrens; Elena Jordana-Lluch; Antonio Oliver; Carlos Juan
Journal:  Biol Rev Camb Philos Soc       Date:  2022-01-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.